180 Wealth Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$200K	Buy	39,430 +10,665	+37%	+$54K	0.03%	400
2025 Q1	$152K	Sell	28,765 -2,465	-8%	-$13K	0.02%	388
2024 Q4	$211K	Buy	31,230 +5,455	+21%	+$36.9K	0.03%	383
2024 Q3	$170K	Buy	25,775 +8,320	+48%	+$54.8K	0.03%	419
2024 Q2	$134K	Buy	+17,455	New	+$134K	0.02%	413